180
Participants
Start Date
August 21, 2018
Primary Completion Date
June 14, 2020
Study Completion Date
June 14, 2020
A/H7N9
Monovalent split 2017 A/H7N9 Inictivated Influenza Virus vaccine containing the HA and NA from low pathogenic avian influenza A/Hong Kong/125/2017 (H7N9) and the PB2, PB1, PA, NP, M and NS from A/Puerto Rico/8/1934 (H1N1).
AS03
AS03 oil-in-water emulsion adjuvant.
Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013
Monovalent split 2013 A/H7N9 Inavtivated Influenza Virus vaccine containing the HA and NA from avian influenza A/Shanghai/2/2013 (H7N9) and the PB2, PB1, PA, NP, M and NS from A/Puerto Rico/8/1934 (H1N1).
Phosphate Buffered Saline (PBS) diluent
Diluent for Influenza Virus Vaccine.
Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham
Emory Children's Center - Pediatric Infectious Diseases, Atlanta
Emory Vaccine Center - The Hope Clinic, Decatur
University of Iowa - Vaccine Research and Education Unit, Iowa City
Saint Louis University - Center for Vaccine Development, St Louis
Baylor College of Medicine - Molecular Virology and Microbiology, Houston
National Institute of Allergy and Infectious Diseases (NIAID)
NIH